2010
DOI: 10.1016/j.bbmt.2009.12.218
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral Airway Function Declines Following Allogeneic Transplantation And Is Associated With The Development Of Chronic GVHD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
0
0
Order By: Relevance
“…Take-home message: there is a consistent suggestion within both paediatric and adult studies that cross-sectional MBW values are more frequently abnormal than spirometry post-HSCT, occurring in all Baseline: FEV 1 abnormal in 13% and D LCO in 70% 1-year follow-up: FEV 1 and FVC at baseline were associated with FEV 1 and FVC at 12 months FEV 1 at 3 months and FVC at all time points were lower than at baseline GVHD: FEV 1 significantly lower in GVHD than non-GVHD subjects BOS/BO: all patients with abnormal FEV 1 at 3 months developed BOS Baseline: LCI abnormal in 48% 1-year follow-up: LCI at baseline and 3 months was not associated with LCI at 12 months; LCI did not change over time GVHD: LCI was significantly higher in GVHD than non-GVHD subjects BOS/BO: abnormal LCI at baseline and 3 months was not associated with development of BOS; absolute median (range) LCI in BOS: 7.9 (6.4-11.8) at baseline, 7.9 (7.4-14.0) at 3 months, 8.4 (6.3-13.0) at 6 months, 8. 4 NA There was evidence of worsened S acin and S cond as compared to healthy controls regardless of the presence of chronic GVHD in other organ systems in subjects without BO In subjects with BO S acin was 551% (SD 360) and worse than in controls (p<0.001); S acin with a 321% cut-off had an 89% sensitivity and 93% specificity in identifying patients with BO LAHZAMI et al [48,88] and PECHEY et al [89] Initial testing (mean±SD or median (range)): FEV 1 was 87±20% pred, FEV 1 /FVC 80 (45-89) FEV 1 was independently associated with time post-HSCT Follow-up: no significant change in spirometry outcomes Initial testing (mean±SD or median (range)): LCI 12.1 (8.0-22.2), S acin 0.24 (0.08-1.72) and S cond 0.07±0.03; S acin was independently associated with time post-HSCT; S acin was correlated with chronic GVHD grade Follow-up: LCI significantly increased from mean±SD 11.6±2.5 to 13.5±3.5 and S acin increased from median 0.28 (range: 0.06-0.69) to 0.41 (0.08-1.07); only change in S acin correlated with change in GVHD grade HTUN et al [50,90] Baseline: mean±SD FEV 1 101±15% pred, FEV nine studies that evaluated this. However, rates of abnormality varied across studies.…”
Section: Rates Of Mbw Abnormality After Hsctmentioning
confidence: 94%
See 1 more Smart Citation
“…Take-home message: there is a consistent suggestion within both paediatric and adult studies that cross-sectional MBW values are more frequently abnormal than spirometry post-HSCT, occurring in all Baseline: FEV 1 abnormal in 13% and D LCO in 70% 1-year follow-up: FEV 1 and FVC at baseline were associated with FEV 1 and FVC at 12 months FEV 1 at 3 months and FVC at all time points were lower than at baseline GVHD: FEV 1 significantly lower in GVHD than non-GVHD subjects BOS/BO: all patients with abnormal FEV 1 at 3 months developed BOS Baseline: LCI abnormal in 48% 1-year follow-up: LCI at baseline and 3 months was not associated with LCI at 12 months; LCI did not change over time GVHD: LCI was significantly higher in GVHD than non-GVHD subjects BOS/BO: abnormal LCI at baseline and 3 months was not associated with development of BOS; absolute median (range) LCI in BOS: 7.9 (6.4-11.8) at baseline, 7.9 (7.4-14.0) at 3 months, 8.4 (6.3-13.0) at 6 months, 8. 4 NA There was evidence of worsened S acin and S cond as compared to healthy controls regardless of the presence of chronic GVHD in other organ systems in subjects without BO In subjects with BO S acin was 551% (SD 360) and worse than in controls (p<0.001); S acin with a 321% cut-off had an 89% sensitivity and 93% specificity in identifying patients with BO LAHZAMI et al [48,88] and PECHEY et al [89] Initial testing (mean±SD or median (range)): FEV 1 was 87±20% pred, FEV 1 /FVC 80 (45-89) FEV 1 was independently associated with time post-HSCT Follow-up: no significant change in spirometry outcomes Initial testing (mean±SD or median (range)): LCI 12.1 (8.0-22.2), S acin 0.24 (0.08-1.72) and S cond 0.07±0.03; S acin was independently associated with time post-HSCT; S acin was correlated with chronic GVHD grade Follow-up: LCI significantly increased from mean±SD 11.6±2.5 to 13.5±3.5 and S acin increased from median 0.28 (range: 0.06-0.69) to 0.41 (0.08-1.07); only change in S acin correlated with change in GVHD grade HTUN et al [50,90] Baseline: mean±SD FEV 1 101±15% pred, FEV nine studies that evaluated this. However, rates of abnormality varied across studies.…”
Section: Rates Of Mbw Abnormality After Hsctmentioning
confidence: 94%
“…Changes over time need to be interpreted within the context of known variability. Specific to this setting, RUTTING et al [51] cGHVD was associated with significant deterioration in FEV 1 and FEF 25-75 compared to those without cGVHD At 3 years post-HSCT, BOS 0p subjects (n=8) had FEV 1 worse than subjects unaffected by BOS 0p/BOS that approached significance cGVHD: significant increases in X rs at 5 Hz, AX and F res as compared to subjects without cGVHD BOS was associated with significant abnormality in X rs at 5 Hz, AX and F res ; oscillometry abnormality was not detected prior to BOS diagnosis BOS 0p (n=8) subjects at 3 years post-HSCT significantly worse X rs at 5 Hz as compared to subjects unaffected by BOS 0p/BOS and this approached significance for F res Adult subjects DE GIACOMI et al [45,86,87] NA Subjects with BO: mean±SD X rs at 5 Hz was −1.84±2.26 and significantly worse than in controls (p=0.023) BLIN et al [52] NA X rs at 5 Hz, AX, F res and R5-R20 were significantly worsened at time of BOS diagnosis as compared to first test; these indices did not change significantly earlier than FEV 1 LAHZAMI et al [48,88] and PECHEY et al [89] Initial testing (mean±SD or median (range)): FEV 1 was 87±20% pred, FEV 1 /FVC 80 ; FEV 1 was independently associated with time post-HSCT Follow-up: no significant change in spirometry outcomes Mean±SD or median (range): R rs at 6 Hz 118±31% pred and X rs at 6 Hz 153 (9-997)% pred Follow-up: median (range) R rs was 103% pred (73-259) and X rs was 172% pred There was no significant change from initial testing BARISIONE et al 2012 [53,91] Baseline: spirometry and oscillometry were within normal range; mean±SD FEV 1 was 3.67±0.74 L, FEV 1 /FVC was 0.81±0.06 Follow-up: there was no significant change in FEV 1 or FEV 1 /FVC, which were mean±SD 3.54±0.75 L and mean±SD 0.81±0.15, respectively Baseline: oscillometry was within normal range, X rs at 5 Hz was −0.50±0.29 Follow-up: X rs at 5 Hz became less negative (p=0.01) and was mean±SD −0.43±0.28 SCHOEFFEL et al [49,59] Baseline: mean±SD FEV 1 was 105±13% pred, FEV 1 /FVC was normal Follow-up: FVC declined Baseline: R rs and X rs at 6 Hz were normal in 91% Follow-up: no changes in R rs and X rs at 6 Hz BOS subjects: R rs and X rs at 6 Hz were all abnormal at time of BOS diagnosis; respiratory function at the visit prior to diagnosis was not different from baseline RUTTING et al [51,92] Mean±SD FEV 1 /FVC ratio was 0.78±0.07…”
Section: Longitudinal Data Change In Oscillometry Indices Over Time A...mentioning
confidence: 95%